SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who started this subject6/4/2003 9:25:59 PM
From: hmpa   of 897
 
NKTR?
1) No meaningful news since winter when the stock was 40% of what it is now - and "McClellan factor" should not work on something clearly not life-saving but rather a thing of convenience (like Exubera)
2) Pfizer doing yet another safety trial and refuses to forecast NDA filing date. Shearwater revenue alone (without any INHL products launched) will not be able to support debt repayment
3) ARDM jumps 25% seemingly for no reason, while NKTR is quite stuck - do ARDM pumpers know something bad about Nektar?
4) Name change <g>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext